Literature DB >> 19643439

Metabolic abnormalities and cardiovascular risk factors in children with myositis.

Kathleen Coyle1, Kristina I Rother, Martina Weise, Alaa Ahmed, Frederick W Miller, Lisa G Rider.   

Abstract

OBJECTIVE: To characterize the metabolic abnormalities and risk factors for future cardiovascular disease in children with myositis. STUDY
DESIGN: Seventeen patients with severe juvenile myositis, primarily referred because of refractory disease, were examined with standardized disease activity and damage measures. Body mass index, fasting insulin and lipid levels, 2-hour oral glucose tolerance test results, and cytokine levels were obtained.
RESULTS: Most patients (71%) had blood pressures >75th percentile; 23.5% of patients had hypertension; and body mass index was >85th percentile in 47%. Metabolic abnormalities were also frequent: 41.2% had an elevated fasting insulin level, 47.1% had hypertriglyceridemia, and 25% met criteria for the metabolic syndrome. Although insulin resistance was common (on the basis of homeostasis model assessment and glucose-to-insulin ratio), insulin secretion appeared to be unaffected. Thigh muscle damage assessed with magnetic resonance imaging significantly correlated with fasting insulin level, glucose level, and glucose-to-insulin ratio. Glucose indices also correlated with the proinflammatory cytokines interleukin (IL)-2 and IL-12 and inversely with anti-inflammatory cytokines IL-1RA and IL-10.
CONCLUSIONS: In this referral cohort of children with severe juvenile myositis, metabolic abnormalities and predictors of cardiovascular disease were common, suggesting an increased risk of future cardiovascular disease. Indicators of insulin resistance correlated with muscle damage on magnetic resonance imaging and proinflammatory cytokines and inversely with anti-inflammatory cytokines.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19643439      PMCID: PMC2809424          DOI: 10.1016/j.jpeds.2009.06.009

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  36 in total

1.  American Academy of Pediatrics. National Cholesterol Education Program: Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.

Authors: 
Journal:  Pediatrics       Date:  1992-03       Impact factor: 7.124

Review 2.  Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease.

Authors:  Ricardo O Escárcega; Mario García-Carrasco; Salvador Fuentes-Alexandro; Luis J Jara; Jorge Rojas-Rodriguez; Luis E Escobar-Linares; Ricard Cervera
Journal:  Autoimmun Rev       Date:  2006-08-02       Impact factor: 9.754

3.  Prevalence of the insulin resistance syndrome in obesity.

Authors:  R M Viner; T Y Segal; E Lichtarowicz-Krynska; P Hindmarsh
Journal:  Arch Dis Child       Date:  2005-01       Impact factor: 3.791

4.  Study of subcutaneous fat in children with juvenile dermatomyositis.

Authors:  Sumit Verma; Surjit Singh; Anil Kumar Bhalla; Madhu Khullar
Journal:  Arthritis Rheum       Date:  2006-08-15

5.  The complex nature of the interaction between disease activity and therapy on the lipid profile in patients with pediatric systemic lupus erythematosus.

Authors:  Talin Sarkissian; Joseph Beyenne; Brian Feldman; Khosrow Adeli; Earl Silverman
Journal:  Arthritis Rheum       Date:  2006-04

6.  Longitudinal study of leptin concentrations during puberty: sex differences and relationship to changes in body composition.

Authors:  M L Ahmed; K K Ong; D J Morrell; L Cox; N Drayer; L Perry; M A Preece; D B Dunger
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

7.  Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus.

Authors:  M Gazarian; B M Feldman; L N Benson; D L Gilday; R M Laxer; E D Silverman
Journal:  J Pediatr       Date:  1998-01       Impact factor: 4.406

8.  A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome.

Authors:  R S Legro; D Finegood; A Dunaif
Journal:  J Clin Endocrinol Metab       Date:  1998-08       Impact factor: 5.958

9.  The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs.

Authors:  P Rahman; D D Gladman; M B Urowitz; K Yuen; D Hallett; I N Bruce
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

10.  RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance.

Authors:  A Morrone; E Pegoraro; C Angelini; E Zammarchi; G Marconi; E P Hoffman
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

View more
  9 in total

1.  Clinical status and cardiovascular risk profile of adults with a history of juvenile dermatomyositis.

Authors:  Micah J Eimer; Wendy J Brickman; Roopa Seshadri; Rosalind Ramsey-Goldman; David D McPherson; Beverly Smulevitz; Neil J Stone; Lauren M Pachman
Journal:  J Pediatr       Date:  2011-07-23       Impact factor: 4.406

2.  Does computed tomography-based muscle density predict muscle function and health-related quality of life in patients with idiopathic inflammatory myopathies?

Authors:  Laura C Cleary; Leslie J Crofford; Douglas Long; Richard Charnigo; Jody Clasey; Francesca Beaman; Kirk A Jenkins; Natasha Fraser; Archana Srinivas; Nicole Dhaon; Beatriz Y Hanaoka
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-07       Impact factor: 4.794

Review 3.  Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment.

Authors:  Lucy R Wedderburn; Lisa G Rider
Journal:  Best Pract Res Clin Rheumatol       Date:  2009-10       Impact factor: 4.098

Review 4.  Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.

Authors:  Judith Wienke; Claire T Deakin; Lucy R Wedderburn; Femke van Wijk; Annet van Royen-Kerkhof
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

Review 5.  Cardiovascular Abnormalities in Juvenile Dermatomyositis: A Scoping Review for the Clinical Rheumatologists.

Authors:  Sanjib Mondal; Prabal Barman; Pandiarajan Vignesh
Journal:  Front Med (Lausanne)       Date:  2022-06-24

6.  British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy.

Authors:  Alexander G S Oldroyd; James B Lilleker; Tania Amin; Octavio Aragon; Katie Bechman; Verna Cuthbert; James Galloway; Patrick Gordon; William J Gregory; Harsha Gunawardena; Michael G Hanna; David Isenberg; John Jackman; Patrick D W Kiely; Polly Livermore; Pedro M Machado; Sue Maillard; Neil McHugh; Ruth Murphy; Clarissa Pilkington; Athiveeraramapandian Prabu; Phoebe Rushe; Stefan Spinty; Joanne Swan; Hasan Tahir; Sarah L Tansley; Paul Truepenny; Yvonne Truepenny; Kishore Warrier; Mark Yates; Charalampia Papadopoulou; Neil Martin; Liza McCann; Hector Chinoy
Journal:  Rheumatology (Oxford)       Date:  2022-05-05       Impact factor: 7.046

Review 7.  Cardiovascular risk in pediatric-onset rheumatological diseases.

Authors:  Julie Barsalou; Timothy J Bradley; Earl D Silverman
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

Review 8.  Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies.

Authors:  Thomas Schwartz; Louise Pyndt Diederichsen; Ingrid E Lundberg; Ivar Sjaastad; Helga Sanner
Journal:  RMD Open       Date:  2016-09-27

9.  Assessment of traditional and non-traditional risk factors for premature atherosclerosis in children with juvenile dermatomyositis and pediatric controls.

Authors:  Dawn M Wahezi; Emily J Liebling; Jaeun Choi; Marija Dionizovik-Dimanovski; Qi Gao; Jillian Parekh
Journal:  Pediatr Rheumatol Online J       Date:  2020-03-18       Impact factor: 3.054

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.